From: Identifying treatment response to antihypertensives in patients with obesity-related hypertension
24-h SBP | P for interaction | ||
---|---|---|---|
Sex | Men | −7 (−12 to −2) | 0.35 |
Women | −4 (−7 to −2) | ||
Age | > 60 years | −4 (−8 to 1) | 0.74 |
≤ 60 years | −7 (−12 to −3) | ||
BMI | > 30.7 kg/m2 | −11 (−18 to −5) | 0.99 |
≤ 30.7 kg/m2 | −4 (−9 to 1) | ||
Waist (sexpooled) | Men > 111 cm Women >98 cm | −8 (−16 to 1) | 0.79 |
Men ≤ 111 cm Women ≤ 98 cm | −6 (−11 to −1) | ||
Heart rateb | > 71/min | −13 (−19 to −7) | 0.03 |
≤ 71/min | −3 (−7 to 2) | ||
MSNA | > 46 bpm | −6 (−14 to 3) | 0.17 |
≤ 46 bpm | −8 (−14 to −1) | ||
hs-CRPc | > 1.8 mg/L | −8 (−14 to −3) | 0.70 |
≤ 1.8 mg/L | −5 (−10 to 0) | ||
Renin | > 57.2 pg/ml | −6 (−12 to 1) | 0.04 |
≤ 57.2 pg/ml | −8 (−13 to −3) | ||
Aldosterone | > 53.4 pg/ml | −8 (−15 to −1) | 0.54 |
≤ 53.4 pg/ml | −7 (−12 to −2) | ||
Sodium intakea | > 87 mmol/day | −7 (−13 to 0) | 0.42 |
≤ 87 mmol/day | −8 (−12 to −3) | ||
Glucose | > 5.1 mmol/L | −8 (−15 to −2) | 0.74 |
≤ 5.1 mmol/L | −6 (−11 to −1) | ||
Adiponectinc | > 68.9 μg/ml | −8 (−13 to −3) | 0.94 |
≤ 68.9 μg/ml | −6 (−13 to 1) | ||
Leptinc | >16.4 ng/ml | −10 (−16 to −4) | 0.29 |
≤16.4 ng/ml | −4 (−10 to 1) |